ARCHIVES

New Drugs Improve Outlook For Bone Marrow Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 3 | March 31, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Statisticians Disputes Bross Claim

April 27, 1979

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

October 1, 1993

NCI Cooperative Group Clinical Trials Approved

June 26, 2009

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

Cancer Policy Board urges distinct care for cancer survivors.

November 11, 2005

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012